28 results on '"Pin, Isabelle"'
Search Results
2. Non-infectious rhinitis is more strongly associated with early—rather than late—onset of COPD: data from the European Community Respiratory Health Survey (ECRHS)
- Author
-
Bergqvist, Joel, Andersson, Anders, Schiöler, Linus, Olin, Anna-Carin, Murgia, Nicola, Bove, Mogens, Janson, Christer, Abramson, Michael J., Leynaert, Bénédicte, Nowak, Dennis, Franklin, Karl A., PIN, Isabelle, Storaas, Torgeir, Schlünssen, Vivi, Heinrich, Joachim, and Hellgren, Johan
- Published
- 2020
- Full Text
- View/download PDF
3. Exposure to Disinfectants and Cleaning Products and Respiratory Health of Workers and Children in Daycares: The CRESPI Cohort Protocol
- Author
-
Le Moual, Nicole, Dumas, Orianne, Bonnet, Pierre, Eworo Nchama, Anastasie, Le Bot, Barbara, Sévin, Etienne, Pin, Isabelle, Siroux, Valérie, Mandin, Corinne, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre Scientifique et Technique du Bâtiment (CSTB), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Laboratoire d'étude et de recherche en environnement et santé (LERES), École des Hautes Études en Santé Publique [EHESP] (EHESP), Département des sciences en santé environnementale (DEESSE), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Laboratoire d épidémiologie des rayonnements ionisants (IRSN/PSE-SANTE/SESANE/LEPID), Service de recherche sur les effets biologiques et Sanitaires des rayonnements ionisants (IRSN/PSE-SANTE/SESANE), and Institut de Radioprotection et de Sûreté Nucléaire (IRSN)-Institut de Radioprotection et de Sûreté Nucléaire (IRSN)
- Subjects
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health ,Epidemiology ,Settled dust ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Environmental and occupational exposures ,Indoor air quality ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Asthma - Abstract
International audience; Although cleaning tasks are frequently performed in daycare, no study has focused on exposures in daycares in relation to respiratory health. The CRESPI cohort is an epidemiological study among workers (n~320) and children (n~540) attending daycares. The purpose is to examine the impact of daycare exposures to disinfectants and cleaning products (DCP) on the respiratory health of workers and children. A sample of 108 randomly selected daycares in the region of Paris has been visited to collect settled dust to analyze semi-volatile organic compounds and microbiota, as well as sample indoor air to analyze aldehydes and volatile organic compounds. Innovative tools (smartphone applications) are used to scan DCP barcodes in daycare and inform their use; a database then matches the barcodes with the products’ compositions. At baseline, workers/parents completed a standardized questionnaire, collecting information on DCP used at home, respiratory health, and potential confounders. Follow-up regarding children’s respiratory health (monthly report through a smartphone application and biannual questionnaires) is ongoing until the end of 2023. Associations between DCP exposures and the respiratory health of workers/children will be evaluated. By identifying specific environments or DCP substances associated with the adverse respiratory health of workers and children, this longitudinal study will contribute to the improvement of preventive measures.
- Published
- 2023
4. Comparison of a Barcode-Based Smartphone Application to a Questionnaire to Assess the Use of Cleaning Products at Home and Their Association with Asthma Symptoms
- Author
-
Lemire, Pierre, Temam, Sofia, Quinot, Catherine, Sévin, Etienne, Remacle, Sophie, Supernant, Karine, Dumas, Orianne, Le Moual, Nicole, Eyriey, E., Licinia, A., Vellement, A., Pin, Isabelle, Hofmann, P., Hullo, Églantine, Llerena, Catherine, Morin, X., Morlot, A., Lepeule, Johanna, Lyon-Caen, Sarah, Philippat, Claire, Quentin, Joane, Siroux, Valérie, Slama, Rémy, Faraldo, Beatrice, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, MGEN Foundation for Public Health [Paris] (FESP-MGEN), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), EpiConcept [Paris], The Sepages Study Group., Fondation d’entreprise MGEN pour la santé publique (FESP MGEN), Anses-PNR-EST-2015-1-022/Ademe-1594C0091, Anses-PNR-EST-2017-1-101/Ademe-1762C0021 Seventh Framework Programme, FP7: FP7/2007-206, N308333-HELIX European Research Council, ERC: N 311765-E-DOHaD Agence Nationale de la Recherche, ANR: 14-CE21-0007-01, 19-CE36-0003-01, ANR 18-CE36-005, ANR-12-PDOC-0029-01, ANR-15-IDEX, ANR-15-IDEX-02 Institut National de la Santé et de la Recherche Médicale, Inserm Fondation de France: CLI-MATHES—00081169 Commissariat Général à l'Investissement, CGI Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail, ANSES: PNR-EST-2018-1-264 Agir pour les Maladies Chroniques, Acknowledgments: We acknowledge the role of SEPAGES cohort study group: E. Eyriey, A. Licinia, A. Vellement (Groupe Hospitalier Mutualiste, Grenoble), I. Pin, P. Hofmann, E. Hullo, C. Llerena (Grenoble University Hospital, La Tronche), X. Morin (Clinique des Cèdres, Echirolles), A. Morlot (Clinique Belledonne, Saint-Martin d’Hères), J. Lepeule, S. Lyon-Caen, C. Philippat, I. Pin, J. Quentin, V. Siroux, R. Slama (Inserm, CNRS, University Grenoble Alpes IAB research center). We thank A. Benlakhryfa, L. Borges, Y. Gioria, clinical research assistants, J. Giraud, M. Marceau, M.-P. Martin, nurses, E. Charvet, A. Putod, midwives, M. Graca, K. Gridel, C. Pelini, fieldworkers, K. Guichardet, A. Levanic, C. Martel, E. Quinteiro neuropsychologists, the sta↵ from Grenoble Center for Clinical Investigation (CIC): J.-L. Cracowski, C. Cracowski, E. Hodaj, D. Abry, N. Gonnet and A. Tournier. A warm thank you also to M. Althuser, S. Althuser, F. Camus-Chauvet, P. Dusonchet, S. Dusonchet, L. Emery, P. Fabbrizio, P. Ho↵mann, D. Marchal André, X. Morin, E. Opoix, L. Pacteau, P. Rivoire, A. Royannais, C. Tomasella, T. Tomasella, D. Tournadre, P. Viossat, E. Volpi, S. Rey, E. Warembourg and clinicians from Grenoble University Hospital for their support in the recruitment of the study volunteers. We also thank A. Buchet, S.F. Caraby, J.-N. Canonica, J. Dujourdil, E. Eyriey, P. Hofmann, M. Jeannin, A. Licina, X. Morin, A. Nicolas, and all midwives from the four maternity wards of Grenoble urban areas. We thank B. Chevolon, C. Cornes, A.S. Gauchez, D. Guergour, P. Faure, J. Arnaud for thyroid hormones assessment. We thank the team of L. Chaperod (EFS) for its implication on the immunological aspects of the project. We thank G. Uzu (IRD) and J.-L. Ja↵rezo (CNRS) for their implication on PM oxidative potential assessment. We thank F.-X. Leupert, O. Bonnet and L. Goirand for the access to the birth certificate database from the Conseil Général de l’Isère. Sépages biospecimens are stored at Grenoble University Hospital (CHU-GA) biobank (bb-0033-00069), we would like to thank the whole CRB team, led by P. Mossuz and P. Lorimier, and in particular the technicians for the huge work of biospecimens processing and pooling: W. Jayar and L. Than, as well as G. Schummer. The Internet platform for secured data collection was developed by Epiconcept Paris (E. Sevin, S. Ployart, A. Polaert). SEPAGES data are stored thanks to Inserm RE-CO-NAI platform funded by Commissariat Général à l’Investissement, with the implication of Sophie de Visme (Inserm DSI). Many thanks to M.A. Charles, RE-CO-NAI coordinator, for her support. Finally, and importantly, we would like to express our sincere thanks to participants of the SEPAGES study. The authors are grateful for the help received from Ines Taarit and Mathias Clément to update the cleaning products ingredients database., Funding: The cohort was supported by the European Research Council (consolidator grant N 311765-E-DOHaD, PI, R. Slama), by the European Community’s Seventh Framework Programme (FP7/2007-206, grant N308333-HELIX, PI, M. Vrijheid), by ANR, the French Research Agency (PAPER project ANR-12-PDOC-0029-01, PI, J. Lepeule, SHALCOH project, 14-CE21-0007-01, PI, R. Slama, GUMME project, PI, R. Slama, ETAPE ANR 18-CE36-005, PI, J. Lepeule, EDeN project 19-CE36-0003-01, SYMER project, ANR-15-IDEX-02, PI, U. Schlattner, Mobil’Air project, ANR-15-IDEX, PI, S. Mathy, supported by University Grenoble-3Alpes), by ANSES (CNAP and HYPAXE projects, PI C. Philippat, PENDORE project, PNR-EST-2018-1-264, PI, V. Siroux), by Plan Cancer (Canc’Air project, PI, P. Guénel), by Association de Recherche sur le Cancer (ARC, PI, P. Guénel), by AGIR pour les maladies chroniques (PI, R. Slama and PRENAPAR project, V. Siroux), and Fonds de Recherche pour la Santé Respiratoire (FRSR, PI, I. Pin) and by Fondation de France (CLI-MATHES—00081169, J. Lepeule). We acknowledge the support of ANSES, Inserm and AGIR pour les maladies chroniques, for SEPAGES feasibility study. The support of 'SCUSI 2017' Région Auvergne-Rhône-Alpes programme is also acknowledged. COBANET-Sepages project was support by Anses and Ademe (COBANET: Anses-PNR-EST-2015-1-022/Ademe-1594C0091, PI: N Le Moual, CRESPINET: Anses-PNR-EST-2017-1-101/Ademe-1762C0021, PI: N Le Moual). Pierre Lemire benefited from a PhD scholarship of the University of Paris-Sud/Paris-Saclay, France., The cohort was supported by the European Research Council (consolidator grant N 311765-E-DOHaD, PI, R. Slama), by the European Community?s Seventh Framework Programme (FP7/2007-206, grant N308333-HELIX, PI, M. Vrijheid), by ANR, the French Research Agency (PAPER project ANR-12-PDOC-0029-01, PI, J. Lepeule, and EDeN project 19-CE36-0003-01, SYMER project, ANR-15-IDEX-02, PI, U. Schlattner, Mobil?Air project, ANR-15-IDEX, PI, S. Mathy, supported by University Grenoble-3Alpes), by ANSES (CNAP and HYPAXE projects, PI C. Philippat, PENDORE project, PNR-EST-2018-1-264, PI, V. Siroux), by Plan Cancer (Canc?Air project, PI, P. Gu?nel), by Association de Recherche sur le Cancer (ARC, PI, P. Gu?nel), by AGIR pour les maladies chroniques (PI, R. Slama and PRENAPAR project, V. Siroux), and Fonds de Recherche pour la Sant? Respiratoire (FRSR, PI, I. Pin) and by Fondation de France (CLIMATHES?00081169, J. Lepeule). We acknowledge the support of ANSES, Inserm and AGIR pour les maladies chroniques, for SEPAGES feasibility study. The support of ?SCUSI 2017? R?gion Auvergne-Rh?ne-Alpes programme is also acknowledged. COBANET-Sepages project was support by Anses and Ademe (COBANET: Anses-PNR-EST-2015-1-022/Ademe-1594C0091, PI: N Le Moual
- Subjects
medicine.medical_specialty ,Health, Toxicology and Mutagenesis ,[SDV]Life Sciences [q-bio] ,lcsh:Medicine ,Smartphone application ,Logistic regression ,Article ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Environmental health ,Epidemiology ,Odds Ratio ,medicine ,Humans ,030212 general & internal medicine ,Association (psychology) ,smartphone application ,Asthma ,household cleaning products ,business.industry ,lcsh:R ,Public Health, Environmental and Occupational Health ,Asthma symptoms ,Odds ratio ,asthma ,medicine.disease ,3. Good health ,030228 respiratory system ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Female ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Smartphone ,business ,Kappa ,Disinfectants - Abstract
International audience; Household disinfectant and cleaning products (HDCPs) assessment is challenging in epidemiological research. We hypothesized that a newly-developed smartphone application was more objective than questionnaires in assessing HDCPs. Therefore, we aimed to compare both methods, in terms of exposure assessments and respiratory health effects estimates. The women of the SEPAGES birth cohort completed repeated validated questionnaires on HDCPs and respiratory health and used an application to report HDCPs and scan products barcodes, subsequently linked with an ingredients database. Agreements between the two methods were assessed by Kappa coefficients. Logistic regression models estimated associations of HDCP with asthma symptom score. The 101 participants (18 with asthma symptom score ≥1) scanned 617 different products (580 with available ingredients list). Slight to fair agreements for sprays, bleach and scented HDCP were observed (Kappa: 0.35, 0.25, 0.11, respectively). Strength of the associations between HDCP and asthma symptom score varied between both methods but all odds ratios (OR) were greater than one. The number of scanned products used weekly was significantly associated with the asthma symptom score (adjusted-OR [CI 95%]: 1.15 [1.00–1.32]). This study shows the importance of using novel tools in epidemiological research to objectively assess HDCP and therefore reduce exposure measurement errors.
- Published
- 2021
5. Regular physical activity levels and incidence of restrictive spirometry pattern: a longitudinal analysis of two population-based cohorts
- Author
-
Carsin, Anne-Elie, Keidel, Dirk, Fuertes, Elaine, Imboden, Medea, Weyler, Joost, Nowak, Dennis, Heinrich, Joachim, Pascual Erquicia Silvia, Martinez-Moratalla, Jesus, Huerta, Ismael, Sanchez, Jose-Luis, Schaffner, Emmanuel, Caviezel, Serena, Beckmeyer-Borowko, Anna, Raherison, Chantal, Pin, Isabelle, Demoly, Pascal, Leynaert, Bénédicte, Cerveri, Isa, Squillacioti, Giulia, Accordini, Simone, Gislason, Thorarinn, Svanes, Cecilie, Toren, Kjell, Forsberg, Bertil, Janson, Christer, Jogi, Rain, Emtner, Margareta, Gómez Real Francisco, Jarvis, Debbie, Guerra, Stefano, Dharmage Shyamali, C, Probst-Hensch, Nicole, Garcia-Aymerich, Judith, and European Union's Horizon 2020 research and innovation programme
- Subjects
BMI ,FVC ,Physical activity ,restrictive spirometry ,spirometry ,Adult ,Aged, 80 and over ,Male ,Epidemiology ,Incidence ,Vital Capacity ,physical activity ,Middle Aged ,Respiration Disorders ,Europe ,Forced Expiratory Volume ,Humans ,Female ,Longitudinal Studies ,Exercise ,01 Mathematical Sciences ,11 Medical and Health Sciences ,Aged - Abstract
A restrictive spirometry pattern is associated with high morbidity and mortality. Whether practicing regular physical activity protects against this pattern has never been studied. We estimated the association between regular physical activity and the incidence of restrictive spirometry pattern. Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and physical activity were assessed between 2000–2002 in the ECRHS (n=2,757, 39-67 years) and SAPALDIA (n=2,610, 36–82 years) population-based European cohorts, and again approximately 10-years later (2010–2013). Subjects with restrictive or obstructive spirometry pattern at baseline were excluded. We assessed the association of being active at baseline (defined as being physically active ≥2-3 times/wk for ≥1 h) with restrictive spirometry pattern at follow-up (defined as a post-bronchodilator FEV1/FVC ≥Lower Limit of Normal and FVC
- Published
- 2020
6. Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort.
- Author
-
Siroux, Valérie, Boudier, Anne, Bousquet, Jean, Dumas, Orianne, Just, Jocelyne, Le Moual, Nicole, Nadif, Rachel, Varraso, Raphaëlle, Valenta, Rudolf, and Pin, Isabelle
- Subjects
IMMUNOGLOBULIN E ,ALLERGENS ,HOUSE dust mites ,ADULTS ,PANEL analysis ,OLDER people - Abstract
Background: Longitudinal studies assessing the association of profiles of allergen‐specific IgE (sIgE) sensitization to a large range of allergen molecules and respiratory health are rare. We aimed to assess trajectories of molecular sIgE sensitization profiles from childhood to adulthood and their associations with respiratory health. Methods: IgE reactivity to microarrayed allergen molecules were measured in childhood (EGEA1) and 12 years later in adult life (EGEA2) among 291 EGEA participants (152 with asthma). At each time point, sIgE sensitization profiles were identified by latent class analysis (LCA) by considering IgE‐reactivity to the 38 most prevalent respiratory allergens. The LCA‐defined profiles were then studied in association with respiratory health. Results: At baseline, the mean (min‐max) age of the population was 11 (4.5–16) years. The LCA identified four sIgE sensitization profiles which were very similar at both time points (% at EGEA1 and EGEA2); A: "no/few allergen(s)" (48%, 39%), B: "pollen/animal allergens" (18%, 21%), C: "most prevalent house dust mite allergens" (22%, 27%) and D: "many allergens" (12%, 13%). Overall, 73% of the participants remained in the same profile from childhood to adulthood. The profiles were associated with asthma and rhinitis phenotypes. Participants of profiles C and D had lower FEV1% and FEF25‐75% as compared to profile A. Similar patterns of associations were observed for participants with asthma. There was no association with change in lung function. Conclusion: Using high‐resolution sIgE longitudinal data, the LCA identified four molecular sensitization profiles, mainly stable from childhood to adulthood, that were associated with respiratory health. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Occupational exposures and incidence of chronic bronchitis and related symptoms over two decades: the European Community Respiratory Health Survey
- Author
-
Lytras, Theodore, Kogevinas, Manolis, Kromhout, Hans, Carsin, Anne Elie, Antó, Josep Maria, Bentouhami, Hayat, Weyler, Joost, Heinrich, Joachim, Nowak, Dennis, Urrutia, Isabel, Martínez-Moratalla, Jesús, Gullón, José Antonio, Vega, Antonio Pereira, Raherison Semjen, Chantal, Pin, Isabelle, Demoly, Pascal, Leynaert, Bénédicte, Villani, Simona, Gíslason, Thorarinn, Svanes, Øistein, Holm, Mathias, Forsberg, Bertil, Norbäck, Dan, Mehta, Amar J., Probst-Hensch, Nicole, Benke, Geza, Jogi, Rain, Torén, Kjell, Sigsgaard, Torben, Schlünssen, Vivi, Olivieri, Mario, Blanc, Paul D., Watkins, John, Bono, Roberto, Buist, A. Sonia, Vermeulen, Roel, Jarvis, Deborah, Zock, Jan Paul, One Health Chemisch, dIRAS RA-2, Dep IRAS, Universitat Pompeu Fabra [Barcelona] (UPF), Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), Center for Genomic Regulation (CRG-UPF), CIBER de Epidemiología y Salud Pública (CIBERESP), Division of Occupational and Environmental Health, Institute for Risk Assessment (IRAS), Utrecht University [Utrecht], University of Antwerp (UA), Universiteit Antwerpen [Antwerpen], Ludwig-Maximilians-Universität München (LMU), Galdakao Hospital, Complejo Hospitalario Universitario de Albacete, Respiratory Department, Hospital Universitario San Agustín (HUSA), Universidad de Huelva, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Sorbonne Université - Département de santé publique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), University of Pavia, Landspitali National University Hospital of Iceland, Haukeland University Hospital, University of Bergen (UiB), University of Gothenburg (GU), Umeå University, Uppsala University Hospital, Boston Public Health Commission (Office of Research and Evaluation), Swiss Tropical and Public Health Institute [Basel], Monash University [Clayton], University of Tartu, Sahlgrenska Academy at University of Gothenburg [Göteborg], Aarhus University Hospital, Department of Public Health [Copenhagen, Denmark] (Danish Ramazzini Centre), Aarhus University [Aarhus]-The National Research Center for Work Environment [Copenhagen, Denmark], University of Verona (UNIVR), University of California [San Francisco] (UCSF), University of California, Cardiff University, University of Turin, Oregon Health and Science University [Portland] (OHSU), University Medical Center [Utrecht], Imperial College London, Salvy-Córdoba, Nathalie, Universiteit Antwerpen = University of Antwerpen [Antwerpen], Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Università degli Studi di Pavia = University of Pavia (UNIPV), Università degli studi di Verona = University of Verona (UNIVR), University of California [San Francisco] (UC San Francisco), University of California (UC), Università degli studi di Torino = University of Turin (UNITO), One Health Chemisch, dIRAS RA-2, Dep IRAS, Medical Research Council (MRC), and Commission of the European Communities
- Subjects
Male ,Chronic bronchitis ,Epidemiology ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,0302 clinical medicine ,1599 Other Commerce, Management, Tourism and Services ,Risk Factors ,Medicine ,longitudinal studies ,030212 general & internal medicine ,Respiratory system ,COPD ,Incidence (epidemiology) ,Incidence ,Longitudinal studies ,epidemiology ,respiratory ,retrospective exposure assessment ,Smoking ,Dust ,Middle Aged ,030210 environmental & occupational health ,3. Good health ,Bronchitis, Chronic ,Europe ,Respiratory ,Female ,Public Health ,Gases ,Adult ,medicine.medical_specialty ,European community ,Pulmonary disease ,Environmental & Occupational Health ,1117 Public Health and Health Services ,03 medical and health sciences ,Internal medicine ,Occupational Exposure ,Humans ,Pesticides ,MESH: Bronchitis, Chronic / etiology ,Gases / adverse effects ,Health Surveys ,Europe / epidemiology ,United States / epidemiology ,Smoking / adverse effects ,Respiratory health ,Retrospective exposure assessment ,business.industry ,Environmental and Occupational Health ,Public Health, Environmental and Occupational Health ,Australia ,1103 Clinical Sciences ,medicine.disease ,United States ,Cough ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Human medicine ,business - Abstract
ObjectivesChronic bronchitis (CB) is an important chronic obstructive pulmonary disease (COPD)-related phenotype, with distinct clinical features and prognostic implications. Occupational exposures have been previously associated with increased risk of CB but few studies have examined this association prospectively using objective exposure assessment. We examined the effect of occupational exposures on CB incidence in the European Community Respiratory Health Survey.MethodsPopulation samples aged 20–44 were randomly selected in 1991–1993, and followed up twice over 20 years. Participants without chronic cough or phlegm at baseline were analysed. Coded job histories during follow-up were linked to the ALOHA Job Exposure Matrix, generating occupational exposure estimates to 12 categories of chemical agents. Their association with CB incidence over both follow-ups was examined with Poisson models using generalised estimating equations.Results8794 participants fulfilled the inclusion criteria, contributing 13 185 observations. Only participants exposed to metals had a higher incidence of CB (relative risk (RR) 1.70, 95% CI 1.16 to 2.50) compared with non-exposed to metals. Mineral dust exposure increased the incidence of chronic phlegm (RR 1.72, 95% CI 1.43 to 2.06). Incidence of chronic phlegm was increased in men exposed to gases/fumes and to solvents and in women exposed to pesticides.ConclusionsOccupational exposures are associated with chronic phlegm and CB, and the evidence is strongest for metals and mineral dust exposure. The observed differences between men and women warrant further investigation.
- Published
- 2019
8. Prevalence of asthma-like symptoms with ageing
- Author
-
Jarvis, Debbie, Newson, Roger, Janson, Christer, Corsico, Angelo, Heinrich, Joachim, Anto, Josep M, Abramson, Michael J, Kirsten, Anne-Marie, Zock, Jan Paul, Bono, Roberto, Demoly, Pascal, Leynaert, Bénédicte, Raherison, Chantal, Pin, Isabelle, Gislason, Thorarinn, Jogi, Rain, Schlunssen, Vivi, Svanes, Cecilie, Watkins, John, Weyler, Joost, Pereira-Vega, Antonio, Urrutia, Isabel, Gullón, Jose A, Forsberg, Bertil, Probst-Hensch, Nicole, Boezen, H Marike, Martinez-Moratalla Rovira, Jesús, Accordini, Simone, de Marco, Roberto, Burney, Peter, Social and Environmental Medicine [Munich, Germany] (Institute and Outpatient Clinic for Occupational), Ludwig-Maximilians University [Munich] (LMU)-University Hospital Munich [Munich, Germany], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cancer environnement (EPICENE ), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Foundation Tartu University Clinics, Lung Clinic, Unit of Epidemiology and Medical Statistics, University of Verona (UNIVR), Groningen Research Institute for Asthma and COPD (GRIAC), Life Course Epidemiology (LCE), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Università degli Studi di Verona, Medical Research Council (MRC), Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, and University of Iceland
- Subjects
Male ,Adult ,Epidemiology ,Aldurshópar ,Respiratory Medicine and Allergy ,[SDV]Life Sciences [q-bio] ,Respiratory System ,Respiratory Epidemiology ,Malalties bronquials ,ECRHS ,smoking ,Cohort Studies ,Arbetsmedicin och miljömedicin ,Young Adult ,Allergic ,nasal allergies ,adults ,Journal Article ,Prevalence ,Humans ,Asma ,Lungmedicin och allergi ,Rhinitis ,Respiratory Sounds ,Rhinitis, Allergic, Seasonal/epidemiology ,Seasonal ,asthma-like symptoms ,Asthma Epidemiology ,Age Factors ,Australia ,Rhinitis, Allergic, Seasonal ,Asthma/complications ,1103 Clinical Sciences ,Öndunarfærasjúkdómar ,Occupational Health and Environmental Health ,Astmi ,Health Surveys ,Bronchial diseases ,Asthma ,Multicenter Study ,Europe ,adults, ageing, asthma, asthma-like symptoms, ECRHS, nasal allergies, prevalence, smoking ,Tíðni ,ageing ,Female ,Human medicine ,Reykingar - Abstract
Publisher's version (útgefin grein), Background Change in the prevalence of asthma-like symptoms in populations of ageing adults is likely to be influenced by smoking, asthma treatment and atopy. Methods The European Community Respiratory Health Survey collected information on prevalent asthma-like symptoms from representative samples of adults aged 20–44 years (29 centres in 13 European countries and Australia) at baseline and 10 and 20 years later (n=7844). Net changes in symptom prevalence were determined using generalised estimating equations (accounting for non-response through inverse probability weighting), followed by meta-analysis of centre level estimates. Findings Over 20 years the prevalence of ‘wheeze’ and ‘wheeze in the absence of a cold’ decreased (−2.4%, 95% CI −3.5 to −1.3%; −1.5%, 95% CI −2.4 to −0.6%, respectively) but the prevalence of asthma attacks, use of asthma medication and hay fever/nasal allergies increased (0.6%, 95% CI 0.1 to 1.11; 3.6%, 95% CI 3.0 to 4.2; 2.7%, 95% CI 1.7 to 3.7). Changes were similar in the first 10 years compared with the second 10 years, except for hay fever/nasal allergies (increase seen in the first 10 years only). Decreases in these wheeze-related symptoms were largely seen in the group who gave up smoking, and were seen in those who reported hay fever/nasal allergies at baseline. Interpretation European adults born between 1946 and 1970 have, over the last 20 years, experienced less wheeze, although they were more likely to report asthma attacks, use of asthma medication and hay fever. Decrease in wheeze is largely attributable to smoking cessation, rather than improved treatment of asthma. It may also be influenced by reductions in atopy with ageing., ECRHS I: The coordination of ECRHS I was supported by the European Commission. The following grants helped fund the local studies. Australia: Asthma Foundation of Victoria, Allen and Hanbury’s, Belgium: Belgian Science Policy Office, National Fund for Scientific Research, Denmark: Aarhus (R Dahl, M Iversen), Estonia: Estonian Science Foundation, grant no. 1088, France: Ministère de la Santé, Glaxo France, Insitut Pneumologique d’Aquitaine, Contrat de Plan Etat-Région Languedoc-Rousillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre delegué de la santé, RNSP, France; GSF, Germany: Bundes minister für Forschung und Technologie, Greece: The Greek Secretary General of Research and Technology, Fisons, Astra and Boehringer-Ingelheim; Italy: Ministero dell’Università e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF no. 381/05.93, Netherlands Dutch Ministry of Wellbeing, Public Health and Culture and the Netherlands Asthma Foundation, Norway: Norwegian Research Council project no. 101422/310; Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa, Spain: Fondo de Investigación Sanitaria (#91/0016-060-05/E, 92/0319 and #93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménez, Dirección Regional de Salud Pública (Consejería de Sanidad del Principado de Asturias), CIRIT (1997 SGR 00079) and Servicio Andaluz de Salud; Sweden: The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy; Switzerland: Swiss National Science Foundation grant 4026- 28099; UK: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority. ECRHS II: The coordination of ECRHS II was supported by the European Commission. The following grants helped fund the local studies. Australia: National Health and Medical Research Council, Belgium: Antwerp: Fund for Scientific Research (grant code, G.0402.00), University of Antwerp, Flemish Health Ministry; Estonia: Tartu Estonian Science Foundation grant no. 4350, France: (All) Programme Hospitalier de Recherche Clinique—Direction de la Recherche Clinique (DRC) de Grenoble 2000 number 2610, Ministry of Health, Ministère de l’Emploi et de la Solidarité, Direction Génerale de la Santé, Centre Hospitalier Universitaire (CHU) de Grenoble, Bordeaux: Institut Pneumologique d’Aquitaine; Grenoble: Comite des Maladies Respiratoires de l’Isere Montpellier: Aventis (France), Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; Paris: Union Chimique Belge-Pharma (France), Aventis (France), Glaxo France, Germany: Erfurt GSF—National Research Centre for Environment and Health, Deutsche Forschungsgemeinschaft (grant code, FR1526/1-1), Hamburg: GSF—National Research Centre for Environment and Health, Deutsche Forschungsgemeinschaft (grant code, MA 711/4-1), Iceland: Reykjavik, Icelandic Research Council, Icelandic University Hospital Fund; Italy: Pavia GlaxoSmithKline Italy, Italian Ministry of University and Scientific and Technological Research (MURST), Local University Funding for Research 1998 and 1999; Turin: Azienda Sanitaria Locale 4 Regione Piemonte (Italy), Azienda Ospedaliera Centro Traumatologico Ospedaliero/Centro Traumatologico Ortopedico—Istituto Clinico Ortopedico Regina Maria Adelaide Regione Piemonte Verona: Ministero dell’Universita e della Ricerca Scientifica (MURST), Glaxo Wellcome SPA, Norway: Bergen: Norwegian Research Council, Norwegian Asthma and Allergy Association, Glaxo Wellcome AS, Norway Research Fund; Spain: Fondo de Investigacion Santarias (grant codes, 97/0035-01, 99/0034-01 and 99/0034 02), Hospital Universitario de Albacete, Consejeria de Sanidad; Barcelona: Sociedad Espanola de Neumologıa y Cirugıa Toracica, Public Health Service (grant code, R01 HL62633-01), Fondo de Investigaciones Santarias (grant codes, 97/0035-01, 99/0034-01 and 99/0034-02), Consell Interdepartamentalde Recerca i Innovacio Tecnologica (grant code, 1999SGR 00241), Instituto de Salud Carlos III; Red de Centros de Epidemiologıa y Salud Publica, C03/09, Red de Bases moleculares y fisiologicas de las Enfermedades Respiratorias, C03/011, and Red de Grupos Infancia y Medio Ambiente G03/176; Huelva: Fondo de Investigaciones Santarias (grant codes, 97/0035-01, 99/0034-01 and 99/0034-02); Galdakao: Basque Health Department Oviedo: Fondo de Investigaciones Sanitaria (97/0035-02, 97/0035, 99/0034-01, 99/0034-02, 99/0034-04, 99/0034-06, 99/350, 99/0034--07), European Commission (EU-PEAL PL01237), Generalitat de Catalunya (CIRIT 1999 SGR 00214), Hospital Universitario de Albacete, Sociedad Española de Neumología y Cirugía Torácica (SEPAR R01 HL62633-01), Red de Centros de Epidemiología y Salud Pública (C03/09), Red de Bases moleculares y fisiológicas de las Enfermedades Respiratorias (C03/011) and Red de Grupos Infancia y Medio Ambiente (G03/176);97/0035-01, 99/0034-01 and 99/0034-02); Sweden: Göteborg, Umea, Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences and Allergy Research, Swedish Asthma and Allergy Foundation, Swedish Cancer and Allergy Foundation, Swedish Council for Working Life and Social Research (FAS), Switzerland: Basel Swiss National Science Foundation, Swiss Federal Office for Education and Science, Swiss National Accident Insurance Fund; UK: Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign). ECRHS III: The coordination of ECRHS III was supported by the Medical Research Council (grant no. 92091). The following grants helped fund the local studies. Australia: National Health and Medical Research Council, Belgium: Antwerp South, Antwerp City: Research Foundation Flanders (FWO), grant code G.0.410.08.N.10 (both sites), Estonia: Tartu-SF0180060s09 from the Estonian Ministry of Education. France: (All) Ministère de la Santé. Programme Hospitalier de Recherche Clinique (PHRC) National 2010. Bordeaux: INSERM U897 Université Bordeaux Segalen, Grenoble: Comite Scientifique AGIRadom 2011. Paris: Agence Nationale de la Santé, Région Ile de France, domaine d’intérêt majeur (DIM) Germany : Erfurt: German Research Foundation HE 3294/10-1, Hamburg: German Research Foundation MA 711/6-1, NO 262/7-1, Iceland: Reykjavik, The Landspitali University Hospital Research Fund, University of Iceland Research Fund, ResMed Foundation, California, USA, Orkuveita Reykjavikur (Geothermal plant), Vegagerðin (The Icelandic Road Administration, ICERA). Italy: All Italian centres were funded by the Italian Ministry of Health, Chiesi Farmaceutici SpA. In addition, Verona was funded by Cariverona Foundation, Education Ministry (MIUR). Norway: Norwegian Research council grant no 214123, Western Norway Regional Health Authorities grant no 911631, Bergen Medical Research Foundation. Spain: Fondo de Investigación Sanitaria (PS09/02457, PS09/00716, PS09/01511, PS09/02185, PS09/03190), Servicio Andaluz de Salud , Sociedad Española de Neumología y Cirurgía Torácica (SEPAR 1001/2010); Sweden: All centres were funded by The Swedish Heart and Lung Foundation, The Swedish Asthma and Allergy Association, The Swedish Association against Lung and Heart Disease. Fondo de Investigación Sanitaria (PS09/02457), Barcelona: Fondo de Investigación Sanitaria (FIS PS09/00716), Galdakao: Fondo de Investigación Sanitaria (FIS 09/01511), Huelva: Fondo de Investigación Sanitaria (FIS PS09/02185), and Servicio Andaluz de Salud Oviedo: Fondo de Investigación Sanitaria (FIS PS09/03190). Sweden: All centres were funded by The Swedish Heart and Lung Foundation, The Swedish Asthma and Allergy Association, The Swedish Association against Lung and Heart Disease. Swedish Research Council for Health, Working Life and Welfare (FORTE) Göteborg : Also received further funding from the Swedish Council for Working Life and Social Research. Umea also received funding from Vasterbotten Country Council ALF grant. Switzerland: The Swiss National Science Foundation (grant nos 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099). The Federal Office for Forest, Environment and Landscape, The Federal Office of Public Health, The Federal Office of Roads and Transport, The Canton’s Government of Aargan, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais and Zürich, the Swiss Lung League, the Canton’s Lung League of Basel Stadt/Basel, Landschaft, Geneva, Ticino, Valais and Zurich, SUVA, Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, Abbott Diagnostics, European Commission 018996 (GABRIEL), Wellcome Trust WT 084703MA, UK: Medical Research Council (grant no 92091). Support was also provided by the National Institute for Health Research through the Primary Care Research Network.
- Published
- 2018
9. Association between air pollution and rhinitis incidence in two European cohorts
- Author
-
Burte, Emilie, Leynaert, Bénédicte, Bono, Roberto, Brunekreef, Bert, Bousquet, Jean, Carsin, Anne-Elie, De Hoogh, Kees, Forsberg, Bertil, Gormand, Frédéric, Heinrich, Joachim, Just, Jocelyne, Marcon, Alessandro, Künzli, Nino, Nieuwenhuijsen, Mark, Pin, Isabelle, Stempfelet, Morgane, Sunyer, Jordi, Villani, Simona, Siroux, Valérie, Jarvis, Deborah, Nadif, Rachel, Jacquemin, Bénédicte, One Health Chemisch, dIRAS RA-2, Vieillissement et Maladies chroniques : approches épidémiologique et de santé publique (VIMA), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidemiology & Pulmonology [Barcelona, Spain] (ISGlobal), Universitat Pompeu Fabra [Barcelona] (UPF)-Centre de Recerca en Epidemiologia Ambiental - CREAL [Barcelona, Spain]-Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), Physiopathologie et Epidémiologie des Maladies Respiratoires (PHERE (UMR_S_1152 / U1152)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Public Health and Pediatrics [Turin, Italy], University of Turin, Institute for Risk Assessment Sciences [Utrecht, The Netherlands] (IRAS), Utrecht University [Utrecht], Julius Center for Health Sciences and Primary Care [Utrecht, The Netherlands], University Medical Center [Utrecht], Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital del Mar Medical Research Institute [Barcelona, Spain] (IMIM), Universitat Pompeu Fabra [Barcelona] (UPF), Swiss Tropical and Public Health Institute [Basel], University of Basel (Unibas), Department of Public Health and Clinical Medicine [Umeå, Sweden] (Environmental and Occupational Medicine), Umeå University, Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Social and Environmental Medicine [Munich, Germany] (Institute and Outpatient Clinic for Occupational), Ludwig-Maximilians University [Munich] (LMU)-University Hospital Munich [Munich, Germany], Centre de l'Asthme et des Allergies [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie (UPMC), Université Pierre et Marie Curie - Paris 6 (UPMC), Department of Diagnostics and Public Health [Verona] (UNIVR | DDSP), University of Verona (UNIVR), Unit of Epidemiology and Medical Statistics [Verona, Italy] (Dept of Diagnostics and Public Health), Service de pédiatrie générale et maladies infectieuses [CHU Grenoble], CHU Grenoble, Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Institut de Veille Sanitaire (INVS), Unit of Biostatistics and Clinical Epidemiology [Pavia, Italy] (Dept of Public Health), University of Pavia-Experimental and Forensic Medicine [Pavia, Italy], School of Public Health [London, UK] (Faculty of Medicine), Imperial College London, Medical Research Council (MRC), One Health Chemisch, dIRAS RA-2, Università degli studi di Torino = University of Turin (UNITO), Ludwig-Maximilians-Universität München (LMU)-University Hospital Munich [Munich, Germany], Università degli studi di Verona = University of Verona (UNIVR), Università degli Studi di Pavia = University of Pavia (UNIPV)-Experimental and Forensic Medicine [Pavia, Italy], and Faraldo, Beatrice
- Subjects
medicine.medical_specialty ,Air pollution ,MEDLINE ,010501 environmental sciences ,medicine.disease_cause ,01 natural sciences ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,air pollution, rhinitis, epidemiology ,Air Pollution ,Epidemiology ,MD Multidisciplinary ,medicine ,Humans ,lcsh:Environmental sciences ,0105 earth and related environmental sciences ,General Environmental Science ,Retrospective Studies ,Rhinitis ,lcsh:GE1-350 ,Air Pollutants ,business.industry ,Incidence (epidemiology) ,Incidence ,Retrospective cohort study ,030228 respiratory system ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,13. Climate action ,epidemiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,Environmental Sciences - Abstract
International audience; BACKGROUND:The association between air pollution and rhinitis is not well established.AIM:The aim of this longitudinal analysis was to study the association between modeled air pollution at the subjects' home addresses and self-reported incidence of rhinitis.METHODS:We used data from 1533 adults from two multicentre cohorts' studies (EGEA and ECRHS). Rhinitis incidence was defined as reporting rhinitis at the second follow-up (2011 to 2013) but not at the first follow-up (2000 to 2007). Annual exposure to NO2, PM10 and PM2.5 at the participants' home addresses was estimated using land-use regression models developed by the ESCAPE project for the 2009-2010 period. Incidence rate ratios (IRR) were computed using Poisson regression. Pooled analysis, analyses by city and meta-regression testing for heterogeneity were carried out.RESULTS:No association between long-term air pollution exposure and incidence of rhinitis was found (adjusted IRR (aIRR) for an increase of 10 μg·m-3 of NO2: 1.00 [0.91-1.09], for an increase of 5 μg·m-3 of PM2.5: 0.88 [0.73-1.04]). Similar results were found in the two-pollutant model (aIRR for an increase of 10 μg·m-3 of NO2: 1.01 [0.87-1.17], for an increase of 5 μg·m-3 of PM2.5: 0.87 [0.68-1.08]). Results differed depending on the city, but no regional pattern emerged for any of the pollutants.CONCLUSIONS:This study did not find any consistent evidence of an association between long-term air pollution and incident rhinitis.
- Published
- 2017
10. Domestic use of cleaning sprays and asthma activity in females
- Author
-
Le Moual, Nicole, Varraso, Raphaëlle, Siroux, Valérie, Dumas, Orianne, Nadif, Rachel, Pin, Isabelle, Zock, Jean-Paul, Kauffmann, Francine, Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de pédiatrie, CHU Grenoble-Hôpital Michallon, Center for Research in Environmental Epidemiology (CREAL), Universitat Pompeu Fabra [Barcelona] (UPF)-Catalunya ministerio de salud, IMIM-Hospital del Mar, Generalitat de Catalunya, CIBER en Epidemiologia y Salud Pública, French Agency of health safety, environment and work (AFSSET, EST-09-15), Merck Sharp & Dohme (MSD), Hospital program of clinical research (PHRC)-Paris, National Research Agency - Health environment, healthwork program (ANR-SEST 2005), Epidemiological Study on the Genetics and Environment of Asthma., and Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF)
- Subjects
cleaning sprays ,immune system diseases ,EGEA ,epidemiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,household exposure ,respiratory tract diseases ,asthma control ,asthma symptom - Abstract
International audience; We aimed to study the associations between the household use of cleaning sprays and asthma symptoms and control of asthma, in females from the Epidemiological Study on the Genetics and Environment of Asthma (EGEA). Data were available for 683 females (mean age 44 yrs, 55% never smokers, 439 without asthma and 244 with current asthma). Both domestic exposures and asthma phenotypes (asthma symptom score, current asthma, poorly-controlled asthma (56%)) were evaluated as previously described in the European Community Respiratory Health Survey. Associations between the use of sprays and asthma phenotypes were evaluated using logistic and nominal regressions, adjusted for age, smoking, body mass index and occupational exposures. Significant associations were observed between the weekly use of at least two types of sprays and a high asthma symptom score (OR (95% CI) 2.50 (1.54-4.03)) compared with a null score. Consistent results were observed for current asthma (1.67 (1.08-2.56)) and poorly-controlled asthma (2.05 (1.25-3.35)) compared with females without asthma. The association for current asthma was higher in females not reporting avoidance of polluted places (2.12 (1.27-3.54)) than in those reporting such avoidance (0.99 (0.53-1.85)). The common use of household cleaning sprays is positively associated with a high asthma symptom score, current asthma and poorly-controlled asthma in females.
- Published
- 2012
11. Asthma severity and exposure to occupational asthmogens
- Author
-
Le Moual, Nicole, Siroux, Valérie, Pin, Isabelle, Kauffmann, Francine, Kennedy, Susan, Faraldo, Beatrice, Epidémiologie et Biostatistique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe de Recherche Sur Le Cancer du Poumon : Bases Moléculaires de la Progression Tumorale, Dépistage et Thérapie Génique, Institut Albert Bonniot-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de médecine aiguë spécialisée, CHU Grenoble-Hôpital Michallon, School of Occupational and Environmental Hygiene, and University of British Columbia (UBC)
- Subjects
MESH: Occupational Diseases ,MESH: Humans ,MESH: Asthma ,asthma severity ,MESH: Molecular Weight ,MESH: Adult ,occupational exposure ,MESH: Air Pollutants, Occupational ,MESH: Case-Control Studies ,MESH: Occupational Exposure ,MESH: Male ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Risk Factors ,MESH: Severity of Illness Index ,epidemiology ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,MESH: Female ,MESH: Detergents - Abstract
EGEA Cooperative group Respiratory epidemiology: INSERM U472, Villejuif: I Annesi-Maesano, F Kauffmann (coordinator), MP Oryszczyn; INSERM U408, Paris: M Korobaeff, F Neukirch. Genetics: INSERM EMI 00-06, Evry: F Demenais; INSERM U535, Villejuif: MH Dizier; INSERM U393, Paris: J Feingold; CNG, Evry: M Lathrop. Clinical centers: Grenoble : I Pin, C Pison; Lyon: D Ecochard (deceased), F Gormand, Y Pacheco; Marseille: D Charpin, D Vervloet; Montpellier: J Bousquet; Paris Cochin: A Lockhart, R Matran (now in Lille) ; Paris Necker : E Paty, P Scheinmann; Paris-Trousseau: A Grimfeld. Data management: INSERM ex-U155: J Hochez ; INSERM U472: N Le Moual.; International audience; RATIONALE: Severe asthma is a public health problem with limited information regarding preventable causes. Although occupational exposures have been implicated as important risk factors for asthma and asthma exacerbations, associations between occupational exposures and asthma severity have not been reported. OBJECTIVE: To examine associations between occupational exposures and asthma severity. METHODS: The Epidemiological Study on the Genetics and Environment of Asthma combines a case-control study with a family study of relatives of patients with asthma. Adult patients (n = 148) were recruited in chest clinics and control subjects without asthma (n = 228) were population-based. Occupational exposures to nonasthmogenic irritants and asthmogens (classified as "any asthmogen" including three broad groups: high-molecular-weight agents, low-molecular-weight agents, and mixed environments) were assessed by an asthma-specific job exposure matrix. Asthma severity was defined from an 8-grade clinical score (frequency of attacks, persistent symptoms, and hospitalization). Patients with severe (score >or= 2) and mild asthma were compared with control subjects using nominal logistic regression. MAIN RESULTS: Significant associations were observed between severe adult-onset asthma and exposure to any occupational asthmogen (odds ratio [OR], 4.0; 95% confidence interval [CI], 2.0-8.1), high-molecular-weight agents (OR, 3.7; CI, 1.3-11.1), low-molecular-weight agents (OR, 4.4; CI, 1.9-10.1), including industrial cleaning agents (OR, 7.2; CI, 1.3-39.9), and mixed environments (OR, 7.5; CI, 2.4-23.5). No significant associations were found between nonasthmogenic irritants and asthma severity, nor between asthmogens and childhood-onset asthma or mild adult-onset asthma. CONCLUSIONS: Our results suggested a strong deleterious role of occupational asthmogens in severe asthma. Clinicians should consider occupational exposures in patients with moderate to severe asthma.
- Published
- 2005
12. The European Community Respiratory Health Survey
- Author
-
Burney, P.G.J., Luczynska, C., Chinn, S., Jarvis, D., Vermeire, Paul, Dahl, R., Nielsen, N., Magnussen, H., Wichmann, H., Papageorgiou, N., Anto, J., Capelastegui, A., Castillo, J., Maldonado, J., Moratalla, J., Quiros, R., Bousquet, J., Neukirch, F., Pin, Isabelle, Taytard, A., Teculescu, D., Prichard, J., Bugiani, Massimiliano, Demarco, R., Cascio, V.L., Rijcken, B., Avila, R., Loureiro, C., Marques, A., Burr, M., Hall, R., Harrison, B., Stark, J., Florey, C., Popp, W., Gislason, T., Gulsvik, Amund, Ackermann-Liebrich, U., Lindholm, N., Boman, G., Rosenhall, L., Aitkhaled, N., Abramson, M., Manfreda, J., Chowgule, R., Crane, J., Stepanov, I., and Buist, S.
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,EUROPE ,Disease ,Pulmonary function testing ,AIRWAY HYPERRESPONSIVENESS ,ALLERGIC DISEASE ,ASTHMA ,Risk Factors ,Surveys and Questionnaires ,Epidemiology ,Health care ,medicine ,Prevalence ,Humans ,European Union ,Respiratory health ,Asthma ,Data collection ,business.industry ,medicine.disease ,respiratory tract diseases ,Family medicine ,Cohort ,Physical therapy ,business - Abstract
The European Community Respiratory Health Survey (ECRHS) was planned to answer specific questions about the distribution of asthma and health care given for asthma in the European Community. Specifically, the survey is designed to estimate variations in the prevalence of asthma, asthma-like symptoms and airway responsiveness; to estimate variations in exposures to known or suspected risk factors for asthma, and assess to what extent these variations explain the variations in the prevalence of disease; and to estimate differences in the use of medication for asthma. The protocol provides specific instructions on the sampling strategy adopted by the survey teams, as well as providing instructions on the use of questionnaires, the tests for allergy, lung function measurements, tests of airway responsiveness, and blood and urine collection. The principal data collection sheets and questionnaires are provided in the appendices, together with information on coding and quality control. The protocol is published as a reference for those who wish to know more of the methods used in the study, and also to give other groups who wish to collect comparable data access to the detailed methodology.
- Published
- 1994
13. Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA Study.
- Author
-
Burte, Emilie, Bousquet, Jean, Varraso, Raphaëlle, Gormand, Frédéric, Just, Jocelyne, Matran, Régis, Pin, Isabelle, Siroux, Valérie, Jacquemin, Bénédicte, and Nadif, Rachel
- Subjects
RHINITIS ,ASTHMA ,EPIDEMIOLOGY ,CONJUNCTIVITIS ,ALLERGENS ,STATISTICAL hypothesis testing - Abstract
Background: The classification of rhinitis in adults is missing in epidemiological studies. Objective: To identify phenotypes of adult rhinitis using an unsupervised approach (data-driven) compared with a classical hypothesis-driven approach. Methods: 983 adults of the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) were studied. Self-reported symptoms related to rhinitis such as nasal symptoms, hay fever, sinusitis, conjunctivitis, and sensitivities to different triggers (dust, animals, hay/flowers, cold air…) were used. Allergic sensitization was defined by at least one positive skin prick test to 12 aeroallergens. Mixture model was used to cluster participants, independently in those without (Asthma-, n = 582) and with asthma (Asthma+, n = 401). Results: Three clusters were identified in both groups: 1) Cluster A (55% in Asthma-, and 22% in Asthma+) mainly characterized by the absence of nasal symptoms, 2) Cluster B (23% in Asthma-, 36% in Asthma+) mainly characterized by nasal symptoms all over the year, sinusitis and a low prevalence of positive skin prick tests, and 3) Cluster C (22% in Asthma-, 42% in Asthma+) mainly characterized by a peak of nasal symptoms during spring, a high prevalence of positive skin prick tests and a high report of hay fever, allergic rhinitis and conjunctivitis. The highest rate of polysensitization (80%) was found in participants with comorbid asthma and allergic rhinitis. Conclusion: This cluster analysis highlighted three clusters of rhinitis with similar characteristics than those known by clinicians but differing according to allergic sensitization, and this whatever the asthma status. These clusters could be easily rebuilt using a small number of variables. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Ten-Year Follow-up of Cluster-based Asthma Phenotypes in Adults: A Pooled Analysis of Three Cohorts.
- Author
-
Boudier, Anne, Curjuric, Ivan, Basagaña, Xavier, Hazgui, Hana, Anto, Josep M., Bousquet, Jean, Bridevaux, Pierre O., Dupuis-Lozeron, Elise, Garcia-Aymerich, Judith, Heinrich, Joachim, Janson, Christer, Künzli, Nino, Leynaert, Bénédicte, de Marco, Roberto, Rochat, Thierry, Schindler, Christian, Varraso, Raphaelle, Pin, Isabelle, Probst-Hensch, Nicole, and Sunyer, Jordi
- Published
- 2013
- Full Text
- View/download PDF
15. Air pollution and asthma control in the Epidemiological study on the Genetics and Environment of Asthma.
- Author
-
Jacquemin, Bénédicte, Kauffmann, Francine, Pin, Isabelle, Le Moual, Nicole, Bousquet, Jean, Gormand, Frédéric, Just, Jocelyne, Nadif, Rachel, Pison, Christophe, Vervloet, Daniel, Künzli, Nino, and Siroux, Valérie
- Subjects
ENVIRONMENTAL monitoring ,AIR pollution ,ASTHMA ,CONFIDENCE intervals ,STATISTICAL correlation ,EPIDEMIOLOGY ,LONGITUDINAL method ,NITROGEN oxides ,RESEARCH funding ,LOGISTIC regression analysis ,DATA analysis ,CROSS-sectional method ,DATA analysis software ,DESCRIPTIVE statistics - Abstract
Background: The associations between exposure to air pollution and asthma control are not well known. The objective of this study was to assess the association between long-term exposure to NO
2 , O3 and PM10 and asthma control in the follow-up of the Epidemiological study on the Genetics and Environment of Asthma(EGEA2) (2003-2007).Methods: Modelled outdoor NO2 , O3 and PM10 estimates were linked to each residential address using the 4 km grid air pollutant surface developed by the French Institute of Environment in 2004. Asthma control was assessed in 481 subjects with current asthma using a multidimensional approach following the 2006-2009Global Initiative for Asthma guidelines. Multinomial and ordinal logistic regressions were conducted adjusted for sex, age, body mass index, education, smoking and use of inhaled corticosteroids. The association between air pollution and the three domains of asthma control(symptoms, exacerbations and lung function) was assessed. ORs are reported per IQR.Results: Median concentrations (in micrograms per cubic metre) were 32 (IQR 25-38) for NO2 (n=465), 46(41-52) for O3 and 21 (18-21) for PM10 (n=481). In total, 44%, 29% and 27% had controlled, partly controlled and uncontrolled asthma, respectively. The ordinal ORs for O3 and PM10 with asthma control were1.69 (95% CI 1.22 to 2.34) and 1.35 (95% CI 1.13 to1.64), respectively. When including both pollutants in the same model, both associations persisted. Associations were not modified by sex, smoking status, use of inhaledcorticosteroids, atopy, season of examination or body mass index. Both pollutants were associated with each of the three main domains of control.Conclusions: The results suggest that long-term exposure to PM10 and O3 is associated with uncontrolled asthma in adults, defined by symptoms, exacerbations and lung function. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
16. Asthma control assessed in the EGEA epidemiological survey and health-related quality of life.
- Author
-
Siroux, Valérie, Boudier, Anne, Bousquet, Jean, Vignoud, Lucile, Gormand, Frédéric, Just, Jocelyne, Le Moual, Nicole, Leynaert, Bénédicte, Nadif, Rachel, Pison, Christophe, Scheinmann, Pierre, Vervloet, Daniel, Anto, Josep Maria, Kauffmann, Francine, and Pin, Isabelle
- Abstract
Summary: Background: The aims were to assess 1) the relationship of asthma control assessed by combining epidemiological survey questions and lung function to Health-Related Quality of Life (HRQL) and 2) whether individuals with controlled asthma reach similar generic HRQL levels as individuals without asthma. Methods: The analysis included 584 individuals without asthma and 498 with asthma who participated in the follow-up of the Epidemiological study on Genetics and Environment of Asthma (EGEA). Asthma control was assessed from survey questions and lung function, closely adapted from the 2006–2009 Global Initiative for Asthma guidelines. The Asthma Quality of Life Questionnaire (AQLQ, scores range:1–7) and the generic SF-36 (scores range: 0–100) were used. Results: Adjusted mean total AQLQ score decreased by 0.5 points for each asthma control steps (6.4, 5.9 and 5.4 for controlled, partly-controlled and uncontrolled asthma respectively, p < 0.0001). The differences in SF-36 scores between individuals with controlled asthma and those without asthma were minor and not significant for the PCS (−1, p = 0.09), borderline significant for the MCS (−1.6, p = 0.05) and small for the 8 domains (<5.1) although statistically significant for 4 domains. Conclusion: These results support the discriminative properties of the proposed asthma control grading system and its use in epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
17. The Impact of Cigarette Smoking on Asthma: A Population-Based International Cohort Study.
- Author
-
Cerveri, Isa, Cazzoletti, Lucia, Corsico, Angelo G., Marcon, Alessandro, Niniano, Rosanna, Grosso, Amelia, Ronzoni, Vanessa, Accordini, Simone, Janson, Christer, Pin, Isabelle, Siroux, Valerie, and de Marco, Roberto
- Subjects
PHYSIOLOGICAL effects of tobacco ,ASTHMA ,EPIDEMIOLOGY ,DISEASE prevalence ,HEALTH outcome assessment ,FOLLOW-up studies (Medicine) ,COHORT analysis - Abstract
Background: The prevalence rates of smoking in subjects with asthma have frequently been reported as similar to those in the general population; however, available data are not up-to-date. There is only limited and somewhat conflicting information on the long-term effects of smoking on health outcomes among population-based cohorts of subjects with asthma. We aimed to investigate changes in smoking habits and their effects on forced expiratory volume in 1 s (FEV
1 ) in subjects with asthma in comparison with the rest of the population, focusing on the healthy smoker effect. Methods: We studied 9,092 subjects without asthma and 1,045 with asthma at baseline who participated in both the European Community Respiratory Health Survey I (20-44 years old in 1991-1993) and II (1999-2002). Results: At follow-up, smoking was significantly less frequent among subjects with asthma than in the rest of the population (26 vs. 31%; p < 0.001). Subjects with asthma who were already ex-smokers at the beginning of the follow-up in the 1990s had the highest mean asthma score (number of reported asthma-like symptoms, range 0-5), probably as a result of the healthy smoker effect (2.80 vs. 2.44 in never smokers, 2.19 in quitters and 2.24 in smokers; p < 0.001). The influence of smoking on FEV1 decline did not depend on asthma status. Smokers had the highest proportion of subjects with chronic cough/phlegm (p < 0.01). Conclusion: One out of 4 subjects with asthma continues smoking and reports significantly more chronic cough and phlegm than never smokers and ex-smokers. This stresses the importance of smoking cessation in all patients with asthma, even in those with less severe asthma. Copyright © 2012 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
18. Prevalence and risk factors of suppurative complications in children with pneumonia.
- Author
-
François, Patrice, Desrumaux, Amélie, Cans, Christine, Pin, Isabelle, Pavese, Patricia, and Labarère, Jos
- Subjects
CEREBROSPINAL meningitis ,PNEUMONIA in children ,ANTIBIOTICS ,ANTI-inflammatory agents ,DRUGS ,IBUPROFEN - Abstract
Aim: To identify the baseline characteristics associated with suppurative complications in children with community-acquired primary pneumonia. Methods: A retrospective study included all children from 28 days to 15 years old, who presented with community-acquired pneumonia at two French hospitals from 1995 to 2003. Complicated pneumonia was defined by the presence of empyema and/or lung abscess. Results: Of 767 children with community-acquired pneumonia, 90 had suppurative complications: 83 cases of pleural empyema and seven cases of lung abscess. The mean prevalence of complicated pneumonia was 3% during the 1995–1998 period, and then steadily increased following a linear trend to reach 23% in 2003. Children with complicated pneumonia were older and had a longer symptomatic period preceding hospitalization. They were more likely to receive antibiotics, especially aminopenicillins (p < 0.01), and nonsteroidal anti-inflammatory drugs, especially ibuprofen (p < 0.001). In multivariable analysis, ibuprofen was the only preadmission therapy that was independently associated with complicated pneumonia [adjusted OR = 2.57 (1.51–4.35)]. Conclusion: This study confirms an association between the use of prehospital ibruprofen and suppurative pneumonic complications. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
19. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults.
- Author
-
Corsico, Angelo G., Cazzoletti, Lucia, de Marco, Roberto, Janson, Christer, Jarvis, Deborah, Zoia, Maria C., Bugiani, Massimiliano, Accordini, Simone, Villani, Simona, Marinoni, Alessandra, Gislason, David, Gulsvik, Amund, Pin, Isabelle, Vermeire, Paul, and Cerveri, Isa
- Abstract
Summary: Background: A major reason of the poor control of asthma is that patients fail to adhere to their treatment. The aim of the study was to identify factors affecting changes in asthma treatment adherence in an international cohort. Methods: A follow-up study was carried out by means of a structured clinical interview in 971 subjects with asthma from 12 countries who participated in both the European Community Respiratory Health Survey: ECRHS-I (1990–94) and ECRHS-II (1998–2002). Subjects were considered adherent if they reported they normally took all the prescribed drugs. A logistic model was used to study the adjusted effect of the determinants. Results: The net change in adherence to anti-asthmatic treatment per 10 years of follow-up was −2% (95% CI: −9.5, 5.5), 7.5% (−2.6, 17.6), 15.0% (6.6, 23.5) and 19.8% (4.1, 35.5), respectively, in Nordic, Mediterranean, Continental and extra-European areas. Among the 428 non-adherent subjects in ECRHS-I, having regular consultations with health care professionals was the strongest predictor of increased adherence (OR 3.32; 95% CI: 1.08–10.17). Among the 543 adherent subjects in ECRHS-I, using inhaled corticosteroids significantly predicted a persistence of adherence (OR 2.04; 95% CI: 1.11–3.75). No effect of gender, age, duration of the disease, smoking habit and educational level was observed. Conclusions: Our findings highlight the key role of doctors and nurses in educating and regularly reviewing the patients and support the efforts for an improvement of clinical communication. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
20. Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study.
- Author
-
Shaaban, Rafea, Kony, Sabine, Driss, Fathi, Leynaert, Bénédicte, Soussan, David, Pin, Isabelle, Neukirch, Françoise, and Zureik, Mahmoud
- Abstract
Summary: Reduced pulmonary function is an important predictor of cardiovascular morbidity and mortality. The mechanisms underlying this association are unknown but may involve systemic inflammation. We assessed the cross-sectional and longitudinal relationships between C-reactive protein (CRP) levels and forced expiratory volume in 1s (FEV
1 ) and its decline in the general population, over a period of 8.5 years. The analyzes were based on 531 subjects (mean age at baseline: 37±7 years, 50% women and 42% non-smokers), recruited at two French centers participating in the European Community Respiratory Health Survey. Lung function was expressed as a percentage of predicted FEV1 . CRP was measured centrally, by means of a highly sensitive assay. In cross-sectional analysis, FEV1 as a % of predicted values was negatively associated with serum CRP concentration (). Multivariate adjustment did not alter these results (). In longitudinal analysis, annual FEV1 decline tended to increase from the lower to the upper tertile for baseline CRP concentration but the association was borderline significant (). Mean values of annual FEV1 decline were 26±32, 31±32, and 34±32ml/year for the lower, middle and upper tertiles of baseline CRP concentration, respectively, after adjusting for potential confounders (). Changes in CRP levels during follow-up were associated with annual FEV1 decline. The mean annual FEV1 declines in subjects with increasing CRP, in those with stable CRP and in those with decreasing CRP were 36±31, 30±31 and 24±31ml/year, respectively (). These findings were not affected by adjustment for potential confounders (). In conclusion, increases in CRP levels over time were associated with a steeper FEV1 decline. [Copyright &y& Elsevier]- Published
- 2006
- Full Text
- View/download PDF
21. Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study.
- Author
-
Siroux, Valérie, Lupinek, Christian, Resch, Yvonne, Curin, Mirela, Just, Jocelyne, Keil, Thomas, Kiss, Renata, Lødrup Carlsen, Karin, Melén, Erik, Nadif, Rachel, Pin, Isabelle, Skrindo, Ingebjørg, Vrtala, Susanne, Wickman, Magnus, Anto, Josep Maria, Valenta, Rudolf, and Bousquet, Jean
- Abstract
Background The nature of allergens and route and dose of exposure may affect the natural development of IgE and IgG responses. Objective We sought to investigate the natural IgE and IgG responses toward a large panel of respiratory and food allergens in subjects exposed to different respiratory allergen loads. Methods A cross-sectional analysis was conducted in 340 adults of the EGEA (Epidemiological study of the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) (170 with and 170 without asthma) cohort. IgE and IgG responses to 47 inhalant and food allergen components were analyzed in sera using allergen microarray and compared between 5 French regions according to the route of allergen exposure (inhaled vs food allergens). Results Overall 48.8% of the population had allergen-specific IgE levels of 0.3 ISAC standardized units (ISU) or more to at least 1 of the 47 allergens with no significant differences across the regions. For ubiquitous respiratory allergens (ie, grass, olive/ash pollen, house dust mites), specific IgE did not show marked differences between regions and specific IgG (≥0.5 ISU) was present in most subjects everywhere. For regionally occurring pollen allergens (ragweed, birch, cypress), IgE sensitization was significantly associated with regional pollen exposure. For airborne allergens cross-reacting with food allergens, frequent IgG recognition was observed even in regions with low allergen prevalence (Bet v 1) or for allergens less frequently recognized by IgE (profilins). Conclusions The variability in allergen-specific IgE and IgG frequencies depends on exposure, route of exposure, and overall immunogenicity of the allergen. Allergen contact by the oral route might preferentially induce IgG responses. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Changes in IgE sensitization and total IgE levels over 20 years of follow-up.
- Author
-
Amaral, André F.S., Newson, Roger B., Abramson, Michael J., Antó, Josep M., Bono, Roberto, Corsico, Angelo G., de Marco, Roberto, Demoly, Pascal, Forsberg, Bertil, Gislason, Thorarinn, Heinrich, Joachim, Huerta, Ismael, Janson, Christer, Jõgi, Rain, Kim, Jeong-Lim, Maldonado, José, Martinez-Moratalla Rovira, Jesús, Neukirch, Catherine, Nowak, Dennis, and Pin, Isabelle
- Abstract
Background Cross-sectional studies have reported a lower prevalence of sensitization in older adults, but few longitudinal studies have examined whether this is an aging or a year-of-birth cohort effect. Objective We sought to assess changes in sensitization and total IgE levels in a cohort of European adults as they aged over a 20-year period. Methods Levels of serum specific IgE to common aeroallergens (house dust mite, cat, and grass) and total IgE levels were measured in 3206 adults from 25 centers in the European Community Respiratory Health Survey on 3 occasions over 20 years. Changes in sensitization and total IgE levels were analyzed by using regression analysis corrected for potential differences in laboratory equipment and by using inverse sampling probability weights to account for nonresponse. Results Over the 20-year follow-up, the prevalence of sensitization to at least 1 of the 3 allergens decreased from 29.4% to 24.8% (−4.6%; 95% CI, −7.0% to −2.1%). The prevalence of sensitization to house dust mite (−4.3%; 95% CI, −6.0% to −2.6%) and cat (−2.1%; 95% CI, −3.6% to −0.7%) decreased more than sensitization to grass (−0.6%; 95% CI, −2.5% to 1.3%). Age-specific prevalence of sensitization to house dust mite and cat did not differ between year-of-birth cohorts, but sensitization to grass was most prevalent in the most recent ones. Overall, total IgE levels decreased significantly (geometric mean ratio, 0.63; 95% CI, 0.58-0.68) at all ages in all year-of-birth cohorts. Conclusion Aging was associated with lower levels of sensitization, especially to house dust mite and cat, after the age of 20 years. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes.
- Author
-
Siroux, Valérie, Boudier, Anne, Dolgopoloff, Maïa, Chanoine, Sébastien, Bousquet, Jean, Gormand, Frederic, Just, Jocelyne, Le Moual, Nicole, Nadif, Rachel, Pison, Christophe, Varraso, Raphaëlle, Matran, Regis, and Pin, Isabelle
- Abstract
Background Whether small-airway obstruction contributes to the long-term evolution of asthma remains unknown. Objectives Our aim was to assess whether the level of forced midexpiratory flow between 25% and 75% of forced vital capacity (FEF 25-75 ) was associated with the persistence of current asthma over 20 years and the subsequent risk for uncontrolled asthma independently of FEV 1 . Methods We studied 337 participants (142 children and 225 adults) with current asthma (asthma attacks or treatment in the past 12 months) recruited to the Epidemiological Study on the Genetics and Environment of Asthma (EGEA1) and followed up at the 12- and 20-year surveys. Persistent current asthma was defined by current asthma reported at each survey. A lung function test and a methacholine challenge test were performed at EGEA1 and EGEA2. Adjusted odds ratios (ORs) were estimated for FEF 25-75 decreased by 10% of predicted value. Results A reduced level of FEF 25-75 at EGEA1 increased the risk of long-term asthma persistence (adjusted OR, 1.14; 95% CI, 1.00-1.29). In children the association remained significant after further adjustment for FEV 1 and in participants with FEV 1 of greater than 80% of predicted value. A reduced FEF 25-75 level at EGEA1 was significantly associated with more severe bronchial hyperresponsiveness ( P < .0001) and with current asthma a decade later, with an association that tended to be stronger in those with (adjusted OR, 1.44; 95% CI, 1.14-1.81) compared with those without (adjusted OR, 1.21; 95% CI, 1.05-1.41) asthma exacerbation. Conclusion Our analysis is the first to suggest that small-airway obstruction, as assessed based on FEF 25-75 , might contribute to the long-term persistence of asthma and the subsequent risk for poor asthma outcomes independently from effects of the large airways. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Mold allergen sensitization in adult asthma according to integrin β3 polymorphisms and Toll-like receptor 2/+596 genotype.
- Author
-
Smit, Lidwien A.M., Bouzigon, Emmanuelle, Bousquet, Jean, Le Moual, Nicole, Nadif, Rachel, Pin, Isabelle, Lathrop, Mark, Demenais, Florence, Kauffmann, Francine, and Siroux, Valérie
- Subjects
ALLERGENS ,ASTHMA ,CLADOSPORIUM ,EPIDEMIOLOGY ,EPISTASIS (Genetics) ,ASPERGILLUS ,CLINICAL immunology - Abstract
Background: Integrin β3 (ITGB3) and Toll-like receptor 2 (TLR2) are candidate genes for asthma and sensitization to mold allergens. Integrin β3 forms a complex with TLR2, and this biological interaction is required for the response of monocytes to TLR2 agonists such as fungal glucan. Objective: To study whether genetic interaction between single nucleotide polymorphisms (SNPs) in genes encoding the TLR2-ITGB3 complex enhances susceptibility to mold sensitization. Methods: Association analysis was conducted in 1243 adults (524 with asthma) who participated in the follow-up of the Epidemiological Study on the Genetics and Environment of Asthma. Allergic sensitization to mold allergens was determined by skin prick testing. Association of mold sensitization with 14 ITGB3 SNPs was tested under an additive genetic model. Interaction between ITGB3 SNPs and TLR2/+596, which was previously shown to be associated with asthma, was studied. Results: A positive skin prick test to mold was found in 115 subjects with asthma (22.0%) and in 61 subjects without asthma (8.5%). The ITGB3 rs2056131 A allele was associated with mold sensitization in subjects with asthma with an odds ratio (95% CI) of 0.60 (0.43-0.83; P = .001). Ten other ITGB3 SNPs were significantly associated with mold sensitization in TLR2/+596TT subjects with asthma (P = .03-.002), whereas much weaker associations were found in carriers of the TLR2/+596 C allele (P = .60-.04). Interaction between TLR2/+596 and these ITGB3 SNPs was statistically significant (P interaction = .05-.001). Conclusion: TLR2/+596 genotype may influence the association between ITGB3 SNPs and mold sensitization in adults with asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
25. Phenotypic determinants of uncontrolled asthma.
- Author
-
Siroux, Valérie, Boudier, Anne, Bousquet, Jean, Bresson, Jean-Louis, Cracowski, Jean-Luc, Ferran, Joane, Gormand, Frédéric, Just, Jocelyne, Le Moual, Nicole, Morange, Sophie, Nadif, Rachel, Oryszczyn, Marie-Pierre, Pison, Christophe, Scheinmann, Pierre, Varraso, Raphaëlle, Vervloet, Daniel, Pin, Isabelle, and Kauffmann, Francine
- Subjects
ASTHMA prevention ,PREVENTIVE medicine ,PHENOTYPES ,ADRENOCORTICAL hormones ,HORMONE therapy ,BODY mass index ,HEALTH surveys ,EPIDEMIOLOGY ,SEX factors in disease - Abstract
Background: Although uncontrolled asthma remains frequent, determinants of asthma control are poorly studied. Objectives: The aim was to estimate the distribution and the phenotypic characteristics of asthma control in 2 groups of subjects defined by the use of inhaled corticosteroids (ICS) in the past 12 months, in the Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy (EGEA). Methods: Five hundred one adult current patients with asthma who participated in the follow-up of the EGEA study were included. Asthma control was assessed from survey questions reflecting asthma control, as defined in the 2006 Global Initiative for Asthma guidelines. The factors analyzed were age, sex, educational level, body mass index, active and passive smoking, sensitization to aeroallergens, total IgE, rhinitis, chronic cough/phlegm, and age at asthma onset. Analyses were stratified according to ICS use. Results: Uncontrolled asthma was more frequent in ICS users (27.6%, 35.0%, and 37.4% with controlled, partly-controlled, and uncontrolled asthma respectively) compared with non-ICS users (60.0%, 23.9%, and 16.1%, respectively). In ICS users, chronic cough or phlegm and female sex were independently and significantly related to uncontrolled asthma. In non-ICS users, high total IgE and sensitization to molds were associated with uncontrolled asthma. Smoking and rhinitis were not associated with asthma control. Conclusion: Optimal asthma control remained unachieved in the majority of patients with asthma in this study. Factors associated with uncontrolled asthma were different in ICS users (chronic cough/phlegm, female sex) and non-ICS users (high total IgE and sensitization to molds). [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
26. Epidemiologic study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy.
- Author
-
Kauffmann, Francine, Dizier, Marie-Hélène, Oryszczyn, Marie-Pierre, Le Moual, Nicole, Siroux, Valérie, Annesi-Maesano, Isabella, Bousquet, Jean, Charpin, Denis, Feingold, Josué, Gormand, Frédéric, Grimfeld, Alain, Matran, Régis, Hochez, Joelle, Lathrop, Mark, Neukirch, Françoise, Paty, Evelyne, Pin, Isabelle, Demenais, Florence, Dizier, Marie-Hélène, and Siroux, Valérie
- Subjects
GENETICS of asthma ,EPIDEMIOLOGY ,BRONCHIAL spasm ,INFLAMMATION ,MEDICAL genetics - Abstract
Summarizes results of the Epidemiologic Study on the Genetics and Environment of Asthma (EGEA), which was planned to assess genetic and environmental risk factors and their interactions in patients with asthma and for the two related traits of bronchial hyperresponsiveness and atopy. Smoking; Occupational exposures to asthma; Segregation analyses of IgE.
- Published
- 2002
- Full Text
- View/download PDF
27. Does consideration of larger study areas yield more accurate estimates of air pollution health effects? An illustration of the bias-variance trade-off in air pollution epidemiology.
- Author
-
Pedersen, Marie, Siroux, Valérie, Pin, Isabelle, Charles, Marie Aline, Forhan, Anne, Hulin, Agnés, Galineau, Julien, Lepeule, Johanna, Giorgis-Allemand, Lise, Sunyer, Jordi, Annesi-Maesano, Isabella, and Slama, Rémy
- Subjects
- *
AIR pollution , *EPIDEMIOLOGY , *CONJOINT analysis , *POPULATION density , *RESPIRATORY organ physiology , *HETEROGENEITY , *COHORT analysis - Abstract
Abstract: Background: Spatially-resolved air pollution models can be developed in large areas. The resulting increased exposure contrasts and population size offer opportunities to better characterize the effect of atmospheric pollutants on respiratory health. However the heterogeneity of these areas may also enhance the potential for confounding. We aimed to discuss some analytical approaches to handle this trade-off. Methods: We modeled NO2 and PM10 concentrations at the home addresses of 1082 pregnant mothers from EDEN cohort living in and around urban areas, using ADMS dispersion model. Simulations were performed to identify the best strategy to limit confounding by unmeasured factors varying with area type. We examined the relation between modeled concentrations and respiratory health in infants using regression models with and without adjustment or interaction terms with area type. Results: Simulations indicated that adjustment for area limited the bias due to unmeasured confounders varying with area at the costs of a slight decrease in statistical power. In our cohort, rural and urban areas differed for air pollution levels and for many factors associated with respiratory health and exposure. Area tended to modify effect measures of air pollution on respiratory health. Conclusions: Increasing the size of the study area also increases the potential for residual confounding. Our simulations suggest that adjusting for type of area is a good option to limit residual confounding due to area-associated factors without restricting the area size. Other statistical approaches developed in the field of spatial epidemiology are an alternative to control for poorly-measured spatially-varying confounders. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
28. Long-term air pollution exposure, greenspace and health-related quality of life in the ECRHS study.
- Author
-
Boudier, Anne, Markevych, Iana, Jacquemin, Bénédicte, Abramson, Michael J., Accordini, Simone, Forsberg, Bertil, Fuertes, Elaine, Garcia-Aymerich, Judith, Heinrich, Joachim, Johannessen, Ane, Leynaert, Bénédicte, Pin, Isabelle, and Siroux, Valérie
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.